| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.0036 | 1 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.0049 | 1 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0035 | 1 |